We are RAYDIAX.

Interventional only.

The world's first therapy-assistance CT system for minimally invasive interventions.

Learn more about the project Join Us

How can we tackle the growing number of cancer cases in the world?

According to the Global Health and Aging report published by the WHO, the number of people aged 65 and older (geriatric population) is projected to rise from 524 million in 2010 to roughly 1.5 billion by 2050. Accordingly, the main cause of death has shifted from contagions to chronic conditions which include cancer, diabetes, and heart diseases. The global incidence of cancer is expected to increase to nearly 27 million by 2030. The geriatric members of society can rarely undergo an open surgery as part of their tumor therapy, due to additional health conditions and expected complications. A plausible solution to this issue is the minimally invasive cancer treatments, which have a lower risk of postoperative complications and require a shorter hospital stay and recovery time.

Our goal is to create and market worldwide the first CT-system solely dedicated to minimally invasive tumor interventions, facilitating both physicians and patients.

RAYDIAX TACT

RAYDIAX TACT is our new therapeutic imaging system allowing faster and safer procedures.

Careers at RAYDIAX

Become part of our team and help us tackle current healthcare challenges.We are continuously looking for innovative and dynamic contributors.

Our Team

Our main goal is to provide a reliable solution to an increasing number of cancer patients.



How to find us


Größere Karte anzeigen

Get in touch

RAYDIAX GmbH
Forschungscampus STIMULATE
Otto-Hahn-Straße 2
39106 Magdeburg
Germany

info@raydiax.com